Samsung Biologics signed a 92.7 billion won CMO contract with MSD

Reporter Kim Jisun / approved : 2024-03-13 03:58:11
  • -
  • +
  • 인쇄

Samsung Biologics. (Photo = Samsung Biologics)

 

[Alpha Biz=(Chicago) Reporter Kim Jisun] Samsung BioLogics said in a public announcement on the 12th that it has signed a KRW 92.7 billion consignment production contract with global pharmaceutical company MSD Switzerland. This is equivalent to 3.09% of sales as of 2022.

The contract period can be changed according to the agreement between the two companies until December 31, 2032.

Alphabiz Reporter Kim Jisun(stockmk2020@alphabiz.co.kr)

어플

주요기사

Financial Supervisory Service to Launch On-Site Inspection of BNK Financial Group Next Month2025.12.22
LG Electronics Partners with Japan’s Top F&B POS Provider Yusen to Roll Out Digital Kiosks Nationwide2025.12.22
Kakao Faces Backlash Over Expanded User Data Collection Starting February 20262025.12.22
Kakao in Talks to Sell Portal “Daum” to AI Startup Upstage2025.12.22
Hanwha Aerospace to Export Korean ‘Cheonmu’ Multiple Rocket Launcher to Estonia2025.12.22
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사